1 The effects of quercetin on drug metabolising enzymes and oxygen radicals were studied in human HepG2 cells.
2 Cytotoxicity of quercetin in HepG2 cells was seen at 50 μM and above as evaluated by lactate dehydrogen ase (LDH) leakage, neutral red (NR) uptake, and 3-(4,5- dimethyl-thiazol-2yl)-2,5-diphenyl tetrazolium bro mide (MTT) reduction.
3 Quercetin inhibited activity of human cytochrome P- 450 towards ethoxycoumarin and ethylresorufin at relatively low substrate concentrations (0.1 μM and above).
4 In comparison to induction by the positive control (β- naphthoflavone; 1.0 μM), quercetin did not signifi cantly induce the metabolism of ethoxycoumarin or glutathione-S-transferase (GST) protein or activity.
5 Response elements for human CYP1A1, GSTλa, xenobiotic response element (XRE), fos, HSP70, CRE, p53, NFκB and DNA damage (GADD) in HepG2 cells were not activated by quercetin.
6 Quercetin exhibited antioxidant activity in HepG2 cells as evidenced by its ability to inhibit the oxidation of the fluorochrome dichlorofluorescin.
7 The results indicate a range of potential beneficial effects of quercetin with respect to the influence on carcinogen-metabolising enzymes, scavenging of re active oxygen species and a lack of stress response in HepG2 cells.
Middleton E.Jr. The flavonoids. Trends in PharmacologicalScience1984; 5: 335-338.
2.
Stavric B., Matula TIBiological significance of flavonoids in foods: A review of some recent issues and problems. Compte Rendu, XIV e Congres International du Groupe Polyphenols (JIEP)1988; pp 95-104. Universite Brock, St. Cantherines, Ontario, Canada, Versailles: INRA Publications.
3.
Macdonald IA , Mader JA, Bussard RGThe role of rutin and quercetin in stimulating flavonol glycosidase activity by cell free microbial preparations of human faeces and saliva. Mutation Research1983; 122: 95-102.
4.
Pamukcu AM, Yalciner S., Hatcher JF, Bryan JTQuercetin a rat intestinal and bladder carcinogen present in bracken fern (Pteridium aquilinum). Cancer Research1980 ; 40: 3468-3472.
5.
Manach C. et al. Quercetin metabolites in plasma of rats fed diets containing rutin and quercetin. Journal of Nutrition1995; 125: 1911-1995.
6.
NTP Technical Report on the Toxicology and carcinogenesis studies of quercetin in F344/N Rats, 1992. NHI Publication No. 91-3140. US. Department of Health and Human Services, Public Health Service, Research Triangle Park, NC, USA.
7.
Laughton MJ, Hallwell B., Evans P., Hoult Jrs.Antioxidant and pro-oxidant action of plant phenolics quercetin, gossypol and myricetin. Biochemical Pharmacology1989 ; 38: 2859-2865.
8.
Alldrick AJ, Flynn J., Rowland IREffect of plant-derived flavonoids and polyphenolic acids on the activity of mutagens from cooked food. Mutation Research1986; 163: 225-232.
9.
Fujiki H., Horiuchi T., Yamashita K.Inhibition of tumour promotion by flavonoids. In: Plant flavonoids in biology and medicine: Biochemical, pharmacological and structure-activity relationships (ed) by Cody V, Middleton E, Harbone JB.1986; p429-440. New York, Alan R. Liss.
10.
Ranelletti FO, Ricci R., Larocca LMGrowth inhibitory effect of quercetin and presence of type-II estrogen-binding sites in human colon-cancer cell lines and primary colorectal tumours. International Journal of Cancer1992; 50: 486-492.
11.
Scambia G., Ranelletti FO, Benedetti PPQuercetin inhibits the growth of multidrug-resistant estrogen-receptor-negative MCF-7 human breast-cancer cell line expressing type-II estrogen-binding sites . Cancer Chemotherapy and Pharmacology1991 ; 28: 255-258.
12.
Scambia G., Ranelletti FO, Benedetti PPInhibitory effect of quercetin on OVCA 433 cells and presence of type-II estrogen binding sites in primary ovarian tumours and cultured cells. British Journal of Cancer1990; 62: 942-947.
13.
Yoshida M., Sakai T., Hosokawa N.The effect of quercetin on cell cycle progression and growth of human gastric cancer cells. FEBS Lett1990; 260: 10-13.
14.
Yoshida M., Yamamoto M., Nikaido T.Quercetin arrests human leukemic T-cells in late G1 phase of the cell cycle . Cancer Research1992; 52: 6676-6681.
15.
Brown JPA review of the genetic effects of naturally occurring flavonoid anthroquinones and related compounds. Mutation Research1980 ; 41: 67-72.
16.
Lee H., Wang H-W., Su H-Y., Hao JNThe structure-activity relationships of flavonoids as inhibitors of cytochrome P-450 enzymes in rat liver microsomes and the mutagenicity of 2-amino-3-methylimidazo[4,5-f] quinoline. Mutagenesis1994; 9(2): 101-106.
17.
Huang MT et al. Specificity in the activation and inhibition by flavonoids of benzo[a]pyrene hydroxylation by cytochrome P450 isoenzymes from rabbit liver microsomes. Journal of Biological Chemistry1981; 256: 10897-10901.
18.
Siess M-H., Guillermic M., LeBon A-M., Suschetet M.Induction of monooxygenase and transferase activities in rat by dietary administration of flavonoids. Xenobiotica1989; 19: 1379-1386.
19.
Anuforo DC, Acosta D., Smith RVHepatotoxicity studies with primary culture of rat liver cells. In Vitro1978; 14: 981-984.
20.
Fautz R., Husein B., Hechenberger C.Application of the neutral red assay (NR assay) to monolayer cultures of primary hepatocytes: rapid colorimetric viability determination for the unscheduled DNA synthesis test (UDS). Mutation Research1991; 253: 173-179.
21.
Hissin JP, Hilf R.A fluorimetric method of determination of oxidized and reduced glutathione in tissues. Analytical Biochemistry1976; 74: 214-226.
22.
Patterson P. , Fry RJ, Horner ASInfluence of cytochrome P-450 type on the pattern of conjugation of 7-hydroxycoumarin generated from 7-ethoxy-coumarin . Xenobiotica1984; 14: 849-859.
23.
Bradford MMA rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein dye binding. Analytical Biochemistry1976; 72: 248-250.
24.
Kennedy SW, Jones SPSimultaneous measurement of cytochrome P4501A catalytic activity and total protein concentration with a fluorescence plate reader. Analytical Biochemistry1994; 222: 217-223.
25.
Pohl RJ, Fouts JRA rapid method for assaying and metabolism of 7-ethoxyresorufin by microsomal subcellular fractions. Analytical Biochemistry1980; 107; 150-155.
26.
Lorenzen A. , Kennedy SWA fluorescence-based protein assay for use with a microplate reader. Analytical Biochemistry1993; 214: 346-348.
27.
Clark AG, Smith JN, Speirs TWCross specificity in some vertebrate and insect glutathione-transferases with methyl parathion (dimethyl p-nitro-phenyl phosphorothionate), 1-chloro-2,4-dinitrobenzene and s-crotonyl-N-acetylcysteamine as substrates. Biochemical Journal1973; 135: 385-392.
28.
Rosenkranz AR et al. A microplate assay for the detection of oxidative products using 2',7'dichlorofluorescin-diacetate. Journal of Immunological Methods1992; 156: 39-45.
29.
Davies JMDetection of peroxyl and alkoxyl radicals produced by reaction of hydroperoxides with rat liver microsomal fractions. Biochemistry Journal1989; 257: 603-606.
30.
Huang X., Frenkel K., Klein CB, Costa M.Nickel induces increased oxidants in intact cultured mammalian cells as detected by dichloro-fluorescin fluorescence. Toxicology and Applied Pharmacology1993; 120: 29-36.
31.
Todd DM et al. TheCAT-Tox (L) assay: a sensitive and specific measure of stress-induced transcription in transformed human liver cells. Fundamental and Applied Toxicology1995; 28: 118-128.
32.
Mosmann T.Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. Journal of Immunological Methods1983; 65: 55-63.
33.
Sousa LR, Marletta MAInhibition of cytochrome P450 activity in rat liver microsomes by naturally occuring flavonoid quercetin. Archives of Biochemistry andBiophysics1985; 240: 345-357.
34.
Sarkar AMQuercetin not only inhibits P-glycoprotein efflux activity but also inhibits CYP3A isoenzymes. Cancer Chemotherapy and Pharmacology1995; 36: 448-450.
35.
Guengerich FPHuman cytochrome P-450 enzymes. In: Cytochrome P-450 structure, mechanism, and biochemistry. Second edition (ed) by Paul R. Ortiz de Montellano1995; pp 473-535. Plenum Press. NY.
36.
Siess M-H. et al. Heterogenous effects of natural flavonoids on mono-oxygenase activities in human and rat microsomes. Toxicology and Applied Pharmacology1995; 130: 73-78.
37.
Buening MK et al. Activation and inhibition of benzo(a)pyrene and aflatoxin B 1 metabolism in human liver microsomes by naturally occurring flavonoids . Cancer Research1981; 41: 67-72.
38.
Merlos M., Sachez RM, Camarasa J., Adzet T.Flavonoids as inhibitors of rat liver cytosolic glutathione-S-transferase . Experientia1989; 47: 616-619.
39.
Brouard C., Siess MH, Vernevaut MF, Suschetet M.Comparison of the effects of feeding quercetin or flavone on hepatic and intestinal drug-metabolizing enzymes of the rat. Food and Chemical Toxicology1988; 26: 99-103.
40.
Gandhi RK, Khanduja KLImpact of quercetin consumption on phase I and phase II drug-metabolizing enzymes in mice. Journal of Clinical Biochemistry and Nutrition1993; 14: 107-112.
41.
Elangovan V. , Sekar N., Govindasamy S.Chemopreventive potential of dietary bioflavonoids against 20-methylcholanthrene-induced tumorigenesis . Cancer Letters1994; 87: 107-113.
42.
Ogawa S., Hirayama T., Tokuda M.The effect of quercetin, a mutagenicity enhancing agent, on the metabolism of 2-acetylaminofluorene with mammalian metabolic activation systems. Mutation Research1986; 162: 179-186.
43.
Ogawa S. et al. Mutagenicity modulating effects of quercetin on aromatic amines and acetamides. Mutation Research1987; 192: 37-46.
44.
Sakai S., Reinhold CE, Wirth PJ, Thorgeirsson SSMechanisms of in vitro mutagenic activation and covalent binding of N-hydroxy-2-acetylaminofluorene in isolated liver cell nuclei from rat and mouse. Cancer Research1978; 38: 2058-2067.
45.
Sahu CSDual role of flavonoids in mutagenesis and carcinogenesis. Environmental Carcinogenesis Ecotoxicology Reviews1994; C12: 1-21.
46.
Ochiai M., Nagoa M., Wakabayashi K., Sugimura T.Superoxide dismutase acts as an enhancing factor for quercetin mutagenesis in rat-liver cytosol by preventing its decomposition. Mutation Research1984; 129: 19-24.
47.
Wang CY, Chiu CW, Pamucku AM, Bryan GTIdentification of carcinogenic tannin isolated from bracken fern (Pteridium aquilinum). Journal of National Cancer Institute1976; 56: 33-36.
48.
Hardigree AA , Epler JLComparative mutagenesis of plant flavonoids in microbial systems. Mutation Research1978 ; 58: 231-239.
49.
Saija A. et al. Flavonoids as antioxidant agents: importance of their interaction with biomembranes. Free RadicalBiology and Medicine1995; 19: 481-486.
50.
Bors W., Heller W., Michel C., Saran M.Flavonoids as antioxidants: Determination of radical-scavenging efficiencies . In: Methods in Enzymology 186: pp 343-355. Academic Press, Inc.New York, 1990 .
51.
Paganga G. et al. Mechanisms of antioxidant activities of quercetin and catechin . Redox Report1996; 2: 359-364.
52.
Puppo A.Effect of flavonoids on hydroxyl radical formation by Fenton-type reactions; influence of the iron chelator. Phytochemistry1992; 31: 85-88.
53.
Helsby NA et al. The isoflavones equol and genistein do not induce xenobiotic-metabolizing enzymes in mouse and human cells. Xenobiotica1997; 27: 587-596.
